市場調査レポート

商品コード

遺伝子編集の世界市場：製品別、サービス別、技法別、技術別、用途別 - 予測（～2029年）

Gene Editing Market by Product, Services, Technique, Technology, Application -Global Forecast to 2029

出版日: 2024年11月15日
発行: MarketsandMarkets
ページ情報: 英文 498 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 720,868円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 968,439円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,186,884円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,456,300円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.63円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の遺伝子編集の市場規模は、2024年の46億6,000万米ドルから2029年までに75億9,000万米ドルに達すると予測され、予測期間にCAGRで10.2%の成長が見込まれます。

調査範囲
調査対象年	2022年～2029年
基準年	2023年
予測期間	2024年～2029年
単位	100万米ドル
セグメント	製品、サービス、技法、技術、用途
対象地域	北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

遺伝子編集技術の進歩、遺伝子編集の利用の拡大といった要因が遺伝子編集市場の成長を促進しています。しかし、遺伝子編集のオフターゲット効果による複数の課題に直面しており、スケーラビリティや製造の難しさとともに、大きなハードルとなっています。

「提供別では、製品セグメントが2023年に遺伝子編集市場で最大のシェアを占めました。」

細胞株開発に向けた実験や研究、医薬品開発と創薬を含む遺伝子編集プロセスにおける製品の需要は、遺伝子市場にとって不可欠なものとなっています。遺伝子編集キット、遺伝子編集試薬、遺伝子編集ライブラリのような試薬・消耗品とソフトウェアシステムとしての遺伝子編集製品は、製薬・バイオテクノロジー企業や学術・研究機関によってさまざまな遺伝子編集ワークフローで利用されています。サービスは2023年に遺伝子編集市場で2番目に高いシェアを占めました。

「技法別では、CRISPR技術が2023年に遺伝子編集製品市場でもっとも高い市場シェアを占めました。」

CRISPRセグメントは、遺伝子編集におけるこの技術の大規模な採用につながるCRISPR技術の進歩により、2023年に技法別の遺伝子編集製品市場でもっとも高いシェアを占めました。遺伝子編集製品は、Cas-9のような試薬、ベクター、スクリーニングや標的同定に用いるライブラリ、CRISPRベースの遺伝子編集キットなど、広範なCRISPR用途で使用されています。それでも、TALENセグメントは2023年に市場で第2位のシェアを占めています。

「アジア太平洋が2024年～2029年に遺伝子編集市場でもっとも高いCAGRで成長しています。」

アジア太平洋は、研究開発活動への大きな注力、遺伝子編集研究における政府と民間企業による資金提供、創薬・医薬品開発における遺伝子編集技術の採用の高まりにより、市場でもっとも急成長しているセグメントであると推定されます。さらに、希少疾患や遺伝性疾患の有病率の上昇は、日本や中国などの国々の高齢化に起因しています。このことが、健康管理と治療における遺伝子編集技術の採用を後押しし、市場成長を促進しています。しかし、北米が2023年に遺伝子編集市場で最大のシェアを占めています。

当レポートでは、世界の遺伝子編集市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

イントロダクション
市場力学
- 促進要因
- 抑制要因
- 機会
- 課題
顧客のビジネスに影響を与える動向/混乱
価格分析
- 主要企業の平均販売価格の動向：消耗品別（2023年）
- 遺伝子編集キット・試薬の平均コスト範囲（2021年～2023年）
- サービスの平均販売価格の動向：タイプ別
- 平均販売価格：地域別
サプライチェーン分析
バリューチェーン分析
エコシステム分析
遺伝子編集市場に対する生成AIの影響
技術分析
- 主要技術
- 補完技術
- 隣接技術
特許分析
主な会議とイベント（2024年～2025年）
規制分析
- 規制情勢
- 規制機関、政府機関、その他の組織
ポーターのファイブフォース分析
主なステークホルダーと購入基準
ケーススタディ分析
投資と資金調達のシナリオ
貿易データアナリティクス
- 輸入データ（2019年～2023年）
- 輸出データ（2019年～2023年）

第6章遺伝子編集市場：製品別

イントロダクション
製品
サービス

第7章遺伝子編集製品市場：タイプ別

イントロダクション
試薬・消耗品
- 遺伝子編集キット
- 遺伝子編集ライブラリ
- 遺伝子編集試薬
ソフトウェア・システム

第8章遺伝子編集試薬と消耗品市場：技法別

イントロダクション
ノックアウト
ノックイン
遺伝子サイレンシング
その他の技法

第9章遺伝子編集製品市場：技術別

イントロダクション
CRISPR
TALEN
ZFN
塩基編集
アンチセンス
RNAI
その他の技術

第10章遺伝子編集製品市場：用途別

イントロダクション
細胞株エンジニアリング
ゲノム編集
創薬・医薬品開発
その他の用途

第11章遺伝子編集製品市場：エンドユーザー別

イントロダクション
製薬・バイオテクノロジー企業
学術・研究機関
CRO・CDMO
その他のエンドユーザー

第12章遺伝子編集サービス市場：タイプ別

イントロダクション
細胞株開発・エンジニアリング
GRNA合成・ベクター構築
ライブラリ構築・スクリーニング
その他のサービス

第13章遺伝子編集サービス市場：用途別

イントロダクション
細胞株エンジニアリング
ゲノム編集
創薬・医薬品開発
その他の用途

第14章遺伝子編集サービス市場：エンドユーザー別

イントロダクション
製薬・バイオテクノロジー企業
学術・研究機関
その他のエンドユーザー

第15章遺伝子編集市場：地域別

イントロダクション
北米
- 北米のマクロ経済の見通し
- 米国
- カナダ
欧州
- 欧州のマクロ経済の見通し
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他の欧州
アジア太平洋
- アジア太平洋のマクロ経済の見通し
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他のアジア太平洋
ラテンアメリカ
- ラテンアメリカのマクロ経済の見通し
- ブラジル
- その他のラテンアメリカ
中東
- 中東のマクロ経済の見通し
- GCC諸国
- その他の中東
アフリカ

第16章競合情勢

イントロダクション
主要企業戦略/有力企業（2021年～2024年）
収益分析（2019年～2023年）
市場シェア分析（2023年）
企業の評価と財務指標
- 企業の評価
- 財務指標
ブランド/製品の比較
- THERMO FISHER SCIENTIFIC INC.（米国）
- MERCK KGAA（ドイツ）
- GENSCRIPT（米国）
- AGILENT TECHNOLOGIES, INC.（米国）
- REVVITY, INC.（米国）
企業の評価マトリクス：主要企業（2023年）
企業の評価マトリクス：スタートアップ/中小企業（2023年）
競合シナリオ

第17章企業プロファイル

主要企業
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGAA
- GENSCRIPT
- AGILENT TECHNOLOGIES, INC.
- REVVITY, INC.
- LONZA
- TECAN TRADING AG
- SANGAMO THERAPEUTICS
- PRECISION BIOSCIENCES
- CELLECTIS S.A.
- REGENERON PHARMACEUTICALS, INC.
- AMSBIO
- CREATIVE BIOGENE
- SYNTHEGO
- TAKARA BIO INC.
- BIO-TECHNE
- CARIBOU BIOSCIENCES, INC.
- BIONEER CORPORATION
- REPROCELL INC.
その他の企業
- ALSTEM INC.
- NEW ENGLAND BIOLABS
- INSCRIPTA, INC.
- BIOCAT GMBH.
- INTEGRATED DNA TECHNOLOGIES, INC.
- COBO TECHNOLOGIES APS
- GENECOPOEIA, INC.
- HERA BIOLABS
- STEMCELL TECHNOLOGIES.
- AXOL BIOSCIENCE LTD.
- CELLECTA, INC.
- APPLIED STEMCELL

第18章付録

図表

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 GENE EDITING MARKET: RISK ASSESSMENT ANALYSIS
TABLE 3 GENE EDITING MARKET: IMPACT ANALYSIS
TABLE 4 APPROVALS FOR PERSONALIZED MEDICINE (GENE THERAPIES), 2023-2024
TABLE 5 PERSONALIZED MEDICINE APPROVALS (GENE THERAPIES) IN 2022
TABLE 6 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021-2023
TABLE 7 AVERAGE SELLING PRICE, BY REGION, 2021-2023 (USD)
TABLE 8 COMMERCIALIZATION OF AI IN GENE EDITING
TABLE 9 GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2024-2025
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 GENE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 15 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 16 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER (2021-2024)
TABLE 17 IMPORT DATA FOR KITS & REAGENTS, BY REGION, 2019-2023 (USD)
TABLE 18 EXPORT DATA FOR KITS & REAGENTS, BY REGION, 2019-2023 (USD THOUSAND)
TABLE 19 GENE EDITING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 20 GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 21 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 22 EUROPE: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 24 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 25 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 26 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 27 GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 28 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 29 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 31 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 32 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 34 GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 35 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 36 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 37 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 38 EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 40 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 41 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 42 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 43 GENE EDITING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 44 NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 45 EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 47 LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 48 MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 49 GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 GENE EDITING LIBRARIES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 51 NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 52 EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 53 ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 54 LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 55 MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 56 GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 57 GENE EDITING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 58 NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 59 EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 60 ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 61 LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 62 MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 63 GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 64 GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 65 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 66 EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 68 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 69 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 70 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 71 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 72 KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 73 NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 74 EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 76 LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 77 MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 79 KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 80 NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 81 EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 84 MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 85 GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 86 GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 87 NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 88 EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 89 ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 90 LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 91 MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 92 GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 93 OTHER TECHNIQUES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 94 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 95 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 97 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 98 MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 99 GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 100 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 101 GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022-2029 (USD MILLION)
TABLE 102 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 103 EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 105 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022-2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 108 GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022-2029 (USD MILLION)
TABLE 109 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 110 EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 111 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022-2029 (USD MILLION)
TABLE 114 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 115 GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022-2029 (USD MILLION)
TABLE 116 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 117 EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 119 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 120 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022-2029 (USD MILLION)
TABLE 121 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022-2029 (USD MILLION)
TABLE 123 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 124 EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022-2029 (USD MILLION)
TABLE 128 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 129 GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022-2029 (USD MILLION)
TABLE 130 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 134 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022-2029 (USD MILLION)
TABLE 135 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 136 GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022-2029 (USD MILLION)
TABLE 137 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 139 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 140 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 141 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022-2029 (USD MILLION)
TABLE 142 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 143 GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 144 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 145 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 147 LATIN AMERICA: GENE EDITING GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 148 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 149 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 150 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 151 CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 152 NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 153 EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 154 ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 155 LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 156 MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 157 GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 158 GENOME EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 159 NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 160 EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 162 LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 163 MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 164 GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 165 DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 166 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 167 EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 168 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 169 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 170 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 171 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) (USD MILLION)
TABLE 172 GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 173 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 174 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 176 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 177 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 178 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 179 GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 180 GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 181 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 182 EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 183 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 184 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 185 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 186 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 187 GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 188 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 189 EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 190 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 191 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 192 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 193 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 194 GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
TABLE 195 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 196 EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 197 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 198 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 199 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
TABLE 200 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 201 GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 202 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 203 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 204 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 205 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 206 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 207 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 208 GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 209 CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 210 NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 211 EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 212 ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 213 LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 214 MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 215 GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 216 GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 217 NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 218 EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 219 ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 220 LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 221 MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 222 GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 223 LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 224 NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 225 EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 226 ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 227 LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 228 MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 229 GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 230 GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 231 NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 232 EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 233 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 234 LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 235 MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 236 GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 237 GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 238 CELL ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 239 NORTH AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 240 EUROPE: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 242 LATIN AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 243 MIDDLE EAST: CELL ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 244 GCC COUNTRIES: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 245 GENOME EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 246 NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 247 EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 248 ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 249 LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 250 MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 251 GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 252 DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 253 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 254 EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 255 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 256 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 257 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 258 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 259 GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 260 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 261 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 262 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 263 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 264 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 265 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 266 GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 267 GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 268 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 269 EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 270 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 271 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 272 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 273 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 274 GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 275 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 276 EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 277 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 278 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 279 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 280 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 281 GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 282 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 283 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 284 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 285 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 286 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 287 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 288 GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 289 GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 290 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 291 NORTH AMERICA GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 292 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 293 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 294 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 295 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 296 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 297 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 298 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 299 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 300 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 301 US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 302 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 303 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 304 US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 305 US: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 306 US: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 307 US: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 308 US: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 309 US: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 310 CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 311 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 312 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 313 CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 314 CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 315 CANADA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 316 CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 317 CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 318 CANADA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 319 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 320 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 321 EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 322 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 323 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 324 EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 325 EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 326 EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 327 EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 328 EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 329 EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 330 EUROPE: MACROECONOMIC INDICATORS
TABLE 331 GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 332 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 333 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 334 GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 335 GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 336 GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 337 GERMANY: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 338 GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 339 GERMANY: GENE EDITING SERVICES MARKET, BY END USERS, 2022-2029 (USD MILLION)
TABLE 340 FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 341 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 342 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 343 FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 344 FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 345 FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 346 FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 347 FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 348 FRANCE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 349 UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 350 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 351 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 352 UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 353 UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 354 UK: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 355 UK: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 356 UK: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 357 UK: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 358 ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 359 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 360 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 361 ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 362 ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 363 ITALY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 364 ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 365 ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 366 ITALY: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 367 SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 368 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 369 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 370 SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 371 SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 372 SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 373 SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 374 SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 375 SPAIN: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 376 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 377 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 378 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 379 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 380 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 381 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 382 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 383 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 384 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 385 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 386 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 387 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 388 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 389 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 390 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 391 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 392 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 393 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 394 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 395 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 396 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 397 CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 398 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 399 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 400 CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 401 CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 402 CHINA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 403 CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 404 CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 405 CHINA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 406 JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 407 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 408 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 409 JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 410 JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 411 JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 412 JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 413 JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 414 JAPAN: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 415 INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 416 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 417 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 418 INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 419 INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 420 INDIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 421 INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 422 INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 423 INDIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 424 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 425 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 426 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 427 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 428 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 429 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 430 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 431 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 432 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 433 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 434 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 435 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 436 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 437 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 438 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 439 AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 440 AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 441 AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 447 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 448 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 449 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 450 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 451 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 452 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 453 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 454 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 455 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 456 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 457 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 458 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 459 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 460 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 461 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 462 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 463 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 464 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 465 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 466 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 467 BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 468 BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 469 BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 470 BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 471 BRAZIL: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 472 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 473 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 474 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 475 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 476 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 477 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 478 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 479 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 480 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 481 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 482 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 483 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 484 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 485 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 486 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 487 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 488 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 489 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 490 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 491 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 492 MIDDLE EAST: MACROECONOMIC INDICATORS
TABLE 493 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 494 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 495 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 496 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 497 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 498 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 499 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 500 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 501 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 502 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 503 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 504 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 505 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 506 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 507 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 508 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 509 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 510 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 511 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 512 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 513 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 514 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 515 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 516 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 517 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 518 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 519 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 520 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 521 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 522 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 523 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 524 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 525 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 526 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 527 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 528 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 529 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 530 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 531 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 532 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 533 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 534 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 535 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 536 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 537 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 538 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 539 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 540 AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 541 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 542 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 543 AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 544 AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 545 AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 546 AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 547 AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 548 AFRICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 549 MACROECONOMIC OUTLOOK FOR AFRICA
TABLE 550 GENE EDITING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021-2024
TABLE 551 GENE EDITING MARKET: DEGREE OF COMPETITION, 2023
TABLE 552 GENE EDITING MARKET: PRODUCT FOOTPRINT
TABLE 553 GENE EDITING MARKET: SERVICE FOOTPRINT
TABLE 554 GENE EDITING MARKET: TECHNOLOGY FOOTPRINT
TABLE 555 GENE EDITING MARKET: APPLICATION FOOTPRINT
TABLE 556 GENE EDITING MARKET: REGION FOOTPRINT
TABLE 557 GENE EDITING MARKET: KEY STARTUPS/SMES
TABLE 558 GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES
TABLE 559 GENE EDITING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
TABLE 560 GENE EDITING MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 561 GENE EDITING MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 562 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 563 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 564 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 565 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 566 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 567 MERCK KGAA: COMPANY OVERVIEW
TABLE 568 MERCK KGAA.: PRODUCTS/SERVICES OFFERED
TABLE 569 MERCK KGAA: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 570 GENSCRIPT: COMPANY OVERVIEW
TABLE 571 GENSCRIPT.: PRODUCTS/SERVICES OFFERED
TABLE 572 GENSCRIPT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
TABLE 573 GENSCRIPT: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 574 GENSCRIPT: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 575 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 576 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 577 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 578 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 579 REVVITY. INC. COMPANY OVERVIEW
TABLE 580 REVVITY, INC.: PRODUCTS/SERVICES OFFERED
TABLE 581 REVIVTY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 582 REVVITY, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 583 LONZA: COMPANY OVERVIEW
TABLE 584 LONZA: PRODUCTS/SERVICES OFFERED
TABLE 585 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 586 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 587 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
TABLE 588 TECAN TRADING AG: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 589 SANGAMO THERAPEUTICS: COMPANY OVERVIEW
TABLE 590 SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 591 SANGAMO THERAPEUTICS: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 592 PRECISION BIOSCIENCES: COMPANY OVERVIEW
TABLE 593 PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED
TABLE 594 PRECISION BIOSCIENCES: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 595 CELLECTIS S.A.: COMPANY OVERVIEW
TABLE 596 CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED
TABLE 597 CELLECTIS S.A.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 598 REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW
TABLE 599 REGENERON PHARMACEUTICALS INC.: PRODUCTS/SERVICES OFFERED
TABLE 600 REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 601 AMSBIO: COMPANY OVERVIEW
TABLE 602 AMSBIO: PRODUCTS/SERVICES OFFERED
TABLE 603 CREATIVE BIOGENE: COMPANY OVERVIEW
TABLE 604 CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED
TABLE 605 SYNTHEGO: COMPANY OVERVIEW
TABLE 606 SYNTHEGO: PRODUCTS/SERVICES OFFERED
TABLE 607 SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 608 SYNTHEGO: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 609 SYNTHEGO: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 610 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 611 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 612 TAKARA BIO INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 613 TAKARA BIO, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 614 BIO-TECHNE: COMPANY OVERVIEW
TABLE 615 BIO-TECHNE.: PRODUCTS/SERVICES OFFERED
TABLE 616 BIO-TECHNE: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 617 BIO-TECHNE: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 618 CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 619 CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 620 CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 621 BIONEER CORPORATION: COMPANY OVERVIEW
TABLE 622 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 623 REPROCELL, INC.: COMPANY OVERVIEW
TABLE 624 REPROCELL, INC.: PRODUCTS/SERVICES OFFERED
TABLE 625 ALSTEM INC.: COMPANY OVERVIEW
TABLE 626 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
TABLE 627 INSCRIPTA, INC.: COMPANY OVERVIEW
TABLE 628 BIOCAT GMBH: COMPANY OVERVIEW
TABLE 629 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 630 COBO TECHNOLOGIES APS.: COMPANY OVERVIEW
TABLE 631 GENECOPOEIA, INC.: COMPANY OVERVIEW
TABLE 632 HERA BIOLABS: COMPANY OVERVIEW
TABLE 633 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 634 AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW
TABLE 635 CELLECTA, INC.: COMPANY OVERVIEW
TABLE 636 APPLIED STEMCELL: COMPANY OVERVIEW

List of Figures

FIGURE 1 RESEARCH DESIGN
FIGURE 2 GENE EDITING MARKET: BREAKDOWN OF PRIMARIES
FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5 ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC.: REVENUE SHARE ANALYSIS (2023)
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 GENE EDITING MARKET: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 GENE EDITING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 11 GENE EDITING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 GENE EDITING PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 15 GENE EDITING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GENE EDITING SERVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GENE EDITING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 18 GEOGRAPHIC SNAPSHOT OF GENE EDITING MARKET
FIGURE 19 INCREASING DEMAND FOR PERSONALIZED MEDICINE AND EXPANDING APPLICATIONS OF GENE EDITING TO DRIVE MARKET
FIGURE 20 REAGENTS & CONSUMABLES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN US IN 2023
FIGURE 21 CELL LINE ENGINEERING TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 22 GENE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 GOVERNMENT FUNDING FOR GENE EDITING PROJECTS, 2019-2023 (USD MILLION)
FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLES (2023)
FIGURE 26 AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
FIGURE 27 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
FIGURE 28 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 29 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
FIGURE 30 GENE EDITING MARKET: TRANSFECTION & SCREENING TO ADD MAXIMUM VALUE TO WORKFLOW
FIGURE 31 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
FIGURE 32 IMPACT OF AI/GEN AI IN GENE EDITING MARKET
FIGURE 33 PATENT APPLICATIONS FOR GENE EDITING (JANUARY 2013-DECEMBER 2023)
FIGURE 34 GENE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FIGURE 36 KEY BUYING CRITERIA OF END USERS, BY PRODUCT
FIGURE 37 KEY BUYING CRITERIA OF END USERS, BY SERVICES
FIGURE 38 NIH FUNDING FOR GENE EDITING PROJECTS
FIGURE 39 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
FIGURE 40 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
FIGURE 41 GENE EDITING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023
FIGURE 42 MARKET SHARE ANALYSIS OF GENE EDITING MARKET, 2023
FIGURE 43 RANKING OF KEY PLAYERS IN GENE EDITING MARKET, 2023
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 45 EV/EBITDA OF KEY PLAYERS
FIGURE 46 GENE EDITING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 48 GENE EDITING MARKET: COMPANY FOOTPRINT
FIGURE 49 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 52 GENSCRIPT: COMPANY SNAPSHOT (2023)
FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55 LONZA: COMPANY SNAPSHOT (2023)
FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2023)
FIGURE 57 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2023)
FIGURE 58 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2023)
FIGURE 59 CELLECTIS S.A.: COMPANY SNAPSHOT (2023)
FIGURE 60 REGENERON PHARMACEUTICALS INC.: COMPANY SNAPSHOT (2023)
FIGURE 61 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 62 BIO-TECHNE: COMPANY SNAPSHOT (2023)
FIGURE 63 CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 64 BIONEER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 65 REPROCELL, INC.: COMPANY SNAPSHOT (2023)

Product Code: BT 3380

The gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2% during the forecast period.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Million)
Segments	by Product, Services, Technique, Technology, Application
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Factors such as advancements in gene editing technologies, and the expanding range of gene editing applications are driving the growth of the gene editing market. However, the market faces several challenges due to off-target effects of gene editing, along with difficulties in scalability and manufacturing, pose significant hurdles.

"The product segment accounted for the largest share by offerings segment in the gene editing market in 2023"

By offerings, the gene editing market is segmented into products and services. The products segment held the largest share in 2023. The demand for products in gene editing process including experimentation and research for cell line development and drug development & discovery make them an indispensable part of the gene market. Gene editing products as reagents & consumables and Software & systems like gene editing kits, gene editing reagents and gene editing libraries are utilized by pharmaceutican & biotechnology companies and academic & research institutes in various gene editing workflow. Services held the second highest share of the gene editing market in 2023.

"The CRISPR technology held the highest market share of the gene editing products market by technology in 2023"

By Technology, the gene editing products market is segmented into CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies which include piggybac and prime editing among others. The CRISPR segment held the highest share of the gene editing products by technology market in 2023 driven by advancements in CRISPR technology leading to large scale adoption of this technology in gene editing. Gene editing products are used in a large range of CRISPR applications including reagents like Cas-9, vectors, libraries for screening and target identification and CRISPR based gene editing kits. Still, TALEN segment held the second largest share of the market in 2023.

"The Asia Pacific region is growing at the highest CAGR in the gene editing market from 2024 to 2029."

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the a significant focus on R&D activities, funding by government and private players in gene editing research, and rising adoption of gene editing technologies in drug discovery & development. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of gene editing technologies in healthcare management and treatment driving the market growth. However, North America held the largest share of gene editing market in 2023.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

Thermo fisher scientific Inc. (US)
Merck KGaA (Germany)
GenScript (US)
Agilent Technologies, Inc. (US)
Revvity (US)
Lonza (US)
Tecan Trading AG (Switzerland)
Sangamo therapeutics (US)
Precision BioSciences (US)
Cellectis S.A. (France)
Regeneron Pharmaceuticals Inc. (US)
AMSBIO (UK)
Creative Biogene (US)
Synthego (US)
Takara Bio Inc. (Japan)
Bio-Techne (US)
Caribou Biosciences, Inc. (US)
Bioneer corporation (South Korea)
REPROCELL Inc. (Japan)

Research Coverage:

This research report categorizes the gene editing market by offerings (products and services), products by type (reagnets & consumables, and software & systems), reagents & consumables by Technique (knock-out, knock-in, gene silencing, and other techniques), products by technology (CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies), products by application (cell line engineering, genome editing/genetic engineering, drug discovery & development, and other applications), products by end user (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and other end users), services by type (cell line engineering, gRNA synthesis & vector construction, library construction & screening, and other types), services by application (cell line development & engineering, genome editing/genetic engineering, drug discovery & development, and other applications), services by end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the genomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the gene editing market. Competitive analysis of top players and upcoming startups in the gene editing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing demand for personalized medicine, Favorable government funding investments for gene editing projects, Expanding applications of gene editing), restraints (Off-Target Effects and Safety Concerns), opportunities (Technological advancements in Prime editing and bridge RNA, Rising burden of congenital disorders), and challenges (Issues with scalability of gene editing workflows. High equipment and facility costs) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched product/services of the gene editing market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the gene editing market
Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript (US), Agilent Technologies, Inc. (US), Revvity (US), Lonza (US), Tecan Trading AG (Switzerland), Sangamo therapeutics (US). Precision BioSciences (US), Cellectis S.A. (France), Regeneron Pharmaceuticals Inc. (US), AMSBIO (UK), Creative Biogene (US), Synthego (US), Takara Bio Inc. (Japan), Bio-Techne (US), Caribou Biosciences, Inc. (US) Bioneer corporation (South Korea), and REPROCELL Inc. (Japan).

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 MARKET ESTIMATION
  - 2.2.1.1 Insights of primary experts
- 2.2.2 SEGMENTAL MARKET SIZE ESTIMATIONS
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 GENE EDITING MARKET OVERVIEW
4.2 NORTH AMERICA: GENE EDITING MARKET, BY TYPE AND COUNTRY (2023)
4.3 GENE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing demand for personalized medicine
  - 5.2.1.2 Favorable government funding investments for gene editing projects
  - 5.2.1.3 Expanding applications of gene editing
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Off-target effects and safety concerns
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Rising technological advancements in prime editing and bridge RNA
  - 5.2.3.2 Increasing burden of congenital disorders
- 5.2.4 CHALLENGES
  - 5.2.4.1 Issues associated with scalability of gene editing workflows
  - 5.2.4.2 High equipment & manufacturing costs
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLE (2023)
- 5.4.2 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021-2023
- 5.4.3 AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
- 5.4.4 AVERAGE SELLING PRICE, BY REGION
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 IMPACT OF GENERATIVE AI ON GENE EDITING MARKET
5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
  - 5.9.1.1 Next-generation sequencing
  - 5.9.1.2 Electroporation
  - 5.9.1.3 Microinjection
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
  - 5.9.2.1 Synthetic biology
  - 5.9.2.2 Data analysis
  - 5.9.2.3 High-throughput screening
- 5.9.3 ADJACENT TECHNOLOGIES
  - 5.9.3.1 Single-cell analysis
  - 5.9.3.2 Optogenetics
  - 5.9.3.3 Gene delivery systems
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES AND EVENTS, 2024-2025
5.12 REGULATORY ANALYSIS
- 5.12.1 REGULATORY LANDSCAPE
  - 5.12.1.1 North America
    - 5.12.1.1.1 US
    - 5.12.1.1.2 Canada
  - 5.12.1.2 Europe
    - 5.12.1.2.1 UK
  - 5.12.1.3 Asia Pacific
    - 5.12.1.3.1 China
    - 5.12.1.3.2 Japan
    - 5.12.1.3.3 South Korea
    - 5.12.1.3.4 Australia
    - 5.12.1.3.5 Rest of Asia Pacific
- 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER'S FIVE FORCES ANALYSIS
- 5.13.1 THREAT OF NEW ENTRANTS
- 5.13.2 THREAT OF SUBSTITUTES
- 5.13.3 BARGAINING POWER OF BUYERS
- 5.13.4 BARGAINING POWER OF SUPPLIERS
- 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 KEY BUYING CRITERIA
5.15 CASE STUDY ANALYSIS
- 5.15.1 ENHANCED GENE KNOCK-IN EFFICIENCY USING HYBRID SSDNA HDR TEMPLATES IN PRIMARY HUMAN T-CELLS
- 5.15.2 GENE EDITING EFFICIENCY IN CANCER CELL LINES AND T-CELLS USING TRUECUT CAS9 PROTEIN V2 AND TRUEGUIDE SGRNA
- 5.15.3 DEVELOPMENT & SPECIFICITY OPTIMIZATION OF PUREDIT CRISPR CAS9 RNP SYSTEM
- 5.15.4 EVALUATION OF SUREGUIDE CAS9 PROGRAMMABLE NUCLEASE KIT FOR EFFICIENT IN VITRO GENE EDITING
- 5.15.5 GENE EDITING FOR SICKLE-CELL DISEASE USING ZINC FINGER NUCLEASE-MODIFIED HEMATOPOIETIC STEM CELLS
5.16 INVESTMENT & FUNDING SCENARIO
- 5.16.1 KEY INVESTMENTS & FUNDING ACTIVITIES, 2021-2024
5.17 TRADE DATA ANALYSIS
- 5.17.1 IMPORT DATA, 2019-2023
- 5.17.2 EXPORT DATA, 2019-2023

6 GENE EDITING MARKET, BY OFFERING

6.1 INTRODUCTION
6.2 PRODUCTS
- 6.2.1 EXPANDING APPLICATIONS OF GENE MODIFICATION TECHNIQUES TO DRIVE MARKET
6.3 SERVICES
- 6.3.1 HIGH UPTAKE BY PHARMA COMPANIES FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET

7 GENE EDITING PRODUCTS MARKET, BY TYPE

7.1 INTRODUCTION
7.2 REAGENTS & CONSUMABLES
- 7.2.1 GENE EDITING KITS
  - 7.2.1.1 Increasing demand for mutation & screening kits in clinical settings to propel market
- 7.2.2 GENE EDITING LIBRARIES
  - 7.2.2.1 Genetic screening for cancer research to fuel uptake
- 7.2.3 GENE EDITING REAGENTS
  - 7.2.3.1 Ability to create animal models to support market growth
7.3 SOFTWARE & SYSTEMS
- 7.3.1 INTEGRATION OF CLOUD-BASED PLATFORMS FOR NGS TO DRIVE MARKET

8 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE

8.1 INTRODUCTION
8.2 KNOCK-OUT
- 8.2.1 MODIFICATION OF CRISPR-CAS9 AND TALENS TO PROPEL MARKET
8.3 KNOCK-IN
- 8.3.1 UTILIZATION OF DONOR DNA TEMPLATES AND HDR PATHWAYS TO DRIVE MARKET
8.4 GENE SILENCING
- 8.4.1 ADVANCEMENTS IN RNAI TECHNOLOGY AND ANTISENSE THERAPY TO SUPPORT MARKET GROWTH
8.5 OTHER TECHNIQUES

9 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY

9.1 INTRODUCTION
9.2 CRISPR
- 9.2.1 ADVANCEMENTS IN CAS9 PROTEINS TO FUEL UPTAKE
9.3 TALENS
- 9.3.1 INCREASING DEMAND FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET
9.4 ZFN
- 9.4.1 PROVISION OF CUSTOMIZED DESIGN AND TARGETED EDITS TO BOOST DEMAND
9.5 BASE EDITING
- 9.5.1 GROWING APPLICATIONS IN FUNCTIONAL GENOMICS TO FUEL MARKET
9.6 ANTISENSE
- 9.6.1 INNOVATIONS IN OLIGONUCLEOTIDE THERAPIES TO SUPPORT MARKET GROWTH
9.7 RNAI
- 9.7.1 WIDE APPLICATIONS IN DRUG DISCOVERY TO FUEL UPTAKE
9.8 OTHER TECHNOLOGIES

10 GENE EDITING PRODUCTS MARKET, BY APPLICATION

10.1 INTRODUCTION
10.2 CELL LINE ENGINEERING
- 10.2.1 ABILITY TO PROVIDE PRECISE GENE MODIFICATIONS FOR VALIDATION TO DRIVE MARKET
10.3 GENOME EDITING
- 10.3.1 GROWING APPLICATIONS IN BIOTECHNOLOGY TO BOOST DEMAND
10.4 DRUG DISCOVERY & DEVELOPMENT
- 10.4.1 UPTAKE OF CRISPR-BASED SYSTEMS FOR DISEASE PROFILING TO DRIVE MARKET
10.5 OTHER APPLICATIONS

11 GENE EDITING PRODUCTS MARKET, BY END USER

11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.2.1 INCREASING PRODUCT APPROVALS AND ROBUST CLINICAL PIPELINE TO PROPEL MARKET
11.3 ACADEMIC & RESEARCH INSTITUTES
- 11.3.1 FAVORABLE FUNDING FOR GENOMIC PROJECTS TO DRIVE MARKET
11.4 CROS & CDMOS
- 11.4.1 PROVISION OF SPECIALIZED EXPERTISE FOR CLINICAL TRIALS TO DRIVE MARKET
11.5 OTHER END USERS

12 GENE EDITING SERVICES MARKET, BY TYPE

12.1 INTRODUCTION
12.2 CELL LINE DEVELOPMENT & ENGINEERING
- 12.2.1 GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET
12.3 GRNA SYNTHESIS & VECTOR CONSTRUCTION
- 12.3.1 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES AND DEMAND FOR PRECISE TARGETING TO DRIVE MARKET
12.4 LIBRARY CONSTRUCTION & SCREENING
- 12.4.1 INCREASING FOCUS ON HIGH-THROUGHPUT SCREENING TO PROPEL MARKET
12.5 OTHER SERVICES
- 12.5.1 OTHER SERVICES INCLUDE OFF-TARGET ANALYSIS AND MUTAGENESIS SERVICES.

13 GENE EDITING SERVICES MARKET, BY APPLICATION

13.1 INTRODUCTION
13.2 CELL LINE ENGINEERING
- 13.2.1 HIGH UPTAKE IN R&D FOR THERAPEUTIC BIOPRODUCTION TO DRIVE MARKET
13.3 GENOME EDITING
- 13.3.1 GROWING FOCUS ON SYNTHETIC GENOMICS TO BOOST DEMAND
13.4 DRUG DISCOVERY & DEVELOPMENT
- 13.4.1 GROWING DEMAND FOR PHARMACEUTICAL DEVELOPMENT TO FUEL UPTAKE
13.5 OTHER APPLICATIONS

14 GENE EDITING SERVICES MARKET, BY END USER

14.1 INTRODUCTION
14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.2.1 GROWING DEMAND FOR ADVANCED MODALITIES TO DRIVE MARKET
14.3 ACADEMIC & RESEARCH INSTITUTES
- 14.3.1 INCREASING FUNDING FOR GENOMIC PROJECTS TO PROPEL MARKET
14.4 OTHER END USERS

15 GENE EDITING MARKET, BY REGION

15.1 INTRODUCTION
15.2 NORTH AMERICA
- 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 15.2.2 US
  - 15.2.2.1 Growing investments by government authorities and private players to drive market
- 15.2.3 CANADA
  - 15.2.3.1 Rise in research & development initiatives for genomics and biotechnology to augment growth
15.3 EUROPE
- 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 15.3.2 GERMANY
  - 15.3.2.1 Growing focus on promoting innovations in biotechnology sector to boost market
- 15.3.3 FRANCE
  - 15.3.3.1 Ongoing clinical trials and advanced genomic research to promote growth
- 15.3.4 UK
  - 15.3.4.1 Growing focus on developing cell and gene therapy infrastructure to fuel market
- 15.3.5 ITALY
  - 15.3.5.1 Increasing availability of research funds to expedite growth
- 15.3.6 SPAIN
  - 15.3.6.1 Booming biotechnology sector to contribute to market growth
- 15.3.7 REST OF EUROPE
15.4 ASIA PACIFIC
- 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 15.4.2 CHINA
  - 15.4.2.1 Increasing affordability of sequencing platforms and procedures to favor growth
- 15.4.3 JAPAN
  - 15.4.3.1 Growing focus on cancer research to fuel market
- 15.4.4 INDIA
  - 15.4.4.1 Increased awareness about therapeutic benefits of genome engineering to encourage growth
- 15.4.5 SOUTH KOREA
  - 15.4.5.1 Rising inclination toward in vivo gene editing to stimulate growth
- 15.4.6 AUSTRALIA
  - 15.4.6.1 Favorable regulatory landscape to sustain growth
- 15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
- 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 15.5.2 BRAZIL
  - 15.5.2.1 Supportive regulatory framework for biotechnology innovation to fuel market
- 15.5.3 REST OF LATIN AMERICA
15.6 MIDDLE EAST
- 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 15.6.2 GCC COUNTRIES
  - 15.6.2.1 Kingdom of Saudi Arabia
    - 15.6.2.1.1 Increasing establishment of biotech startups to support market growth
  - 15.6.2.2 United Arab Emirates (UAE)
    - 15.6.2.2.1 Growing collaborations for genome sequencing to drive market
  - 15.6.2.3 Other GCC Countries
- 15.6.3 REST OF MIDDLE EAST
15.7 AFRICA
- 15.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
- 15.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

16 COMPETITIVE LANDSCAPE

16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
16.3 REVENUE ANALYSIS, 2019-2023
16.4 MARKET SHARE ANALYSIS, 2023
- 16.4.1 RANKING OF KEY MARKET PLAYERS
16.5 COMPANY VALUATION AND FINANCIAL METRICS
- 16.5.1 COMPANY VALUATION
- 16.5.2 FINANCIAL METRICS
16.6 BRAND/PRODUCT COMPARISON
- 16.6.1 THERMO FISHER SCIENTIFIC INC. (US)
- 16.6.2 MERCK KGAA (GERMANY)
- 16.6.3 GENSCRIPT (US)
- 16.6.4 AGILENT TECHNOLOGIES, INC. (US)
- 16.6.5 REVVITY, INC. (US)
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 16.7.1 STARS
- 16.7.2 EMERGING LEADERS
- 16.7.3 PERVASIVE PLAYERS
- 16.7.4 PARTICIPANTS
- 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 16.7.5.1 Company footprint
  - 16.7.5.2 Product footprint
  - 16.7.5.3 Service footprint
  - 16.7.5.4 Technology footprint
  - 16.7.5.5 Region footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 16.8.1 PROGRESSIVE COMPANIES
- 16.8.2 RESPONSIVE COMPANIES
- 16.8.3 DYNAMIC COMPANIES
- 16.8.4 STARTING BLOCKS
- 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 16.8.5.1 Detailed list of key startups/SMEs
  - 16.8.5.2 Competitive benchmarking of key startups/SMEs
16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
- 16.9.2 DEALS
- 16.9.3 EXPANSIONS

17 COMPANY PROFILES

17.1 KEY PLAYERS
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
  - 17.1.1.1 Business overview
  - 17.1.1.2 Products/Services offered
  - 17.1.1.3 Recent developments
    - 17.1.1.3.1 Product/Service launches & approvals
    - 17.1.1.3.2 Deals
    - 17.1.1.3.3 Expansions
  - 17.1.1.4 MnM view
    - 17.1.1.4.1 Key strengths
    - 17.1.1.4.2 Strategic choices
    - 17.1.1.4.3 Weaknesses & competitive threats
- 17.1.2 MERCK KGAA
  - 17.1.2.1 Business overview
  - 17.1.2.2 Products/Services offered
  - 17.1.2.3 Recent developments
    - 17.1.2.3.1 Deals
  - 17.1.2.4 MnM view
    - 17.1.2.4.1 Key strengths
    - 17.1.2.4.2 Strategic choices
    - 17.1.2.4.3 Weaknesses & competitive threats
- 17.1.3 GENSCRIPT
  - 17.1.3.1 Business overview
  - 17.1.3.2 Products/Services offered
  - 17.1.3.3 Recent developments
    - 17.1.3.3.1 Product/Service launches & approvals
    - 17.1.3.3.2 Deals
    - 17.1.3.3.3 Expansions
  - 17.1.3.4 MnM view
    - 17.1.3.4.1 Key strengths
    - 17.1.3.4.2 Strategic choices
    - 17.1.3.4.3 Weaknesses and competitive threats
- 17.1.4 AGILENT TECHNOLOGIES, INC.
  - 17.1.4.1 Business overview
  - 17.1.4.2 Products/Services offered
  - 17.1.4.3 Recent developments
    - 17.1.4.3.1 Deals
    - 17.1.4.3.2 Expansions
  - 17.1.4.4 MnM view
    - 17.1.4.4.1 Key strengths
    - 17.1.4.4.2 Strategic choices
    - 17.1.4.4.3 Weaknesses & competitive threats
- 17.1.5 REVVITY, INC.
  - 17.1.5.1 Business overview
  - 17.1.5.2 Products/Services offered
  - 17.1.5.3 Recent developments
    - 17.1.5.3.1 Product/Service launches
    - 17.1.5.3.2 Deals
  - 17.1.5.4 MnM view
    - 17.1.5.4.1 Key strengths
    - 17.1.5.4.2 Strategic choices
    - 17.1.5.4.3 Weakness & competitive threats
- 17.1.6 LONZA
  - 17.1.6.1 Business overview
  - 17.1.6.2 Products/Services offered
  - 17.1.6.3 Recent developments
    - 17.1.6.3.1 Product/Service launches
- 17.1.7 TECAN TRADING AG
  - 17.1.7.1 Business overview
  - 17.1.7.2 Products/Services offered
  - 17.1.7.3 Recent developments
    - 17.1.7.3.1 Deals
- 17.1.8 SANGAMO THERAPEUTICS
  - 17.1.8.1 Business overview
  - 17.1.8.2 Products/Services offered
  - 17.1.8.3 Recent developments
    - 17.1.8.3.1 Deals
- 17.1.9 PRECISION BIOSCIENCES
  - 17.1.9.1 Business overview
  - 17.1.9.2 Products/Services offered
  - 17.1.9.3 Recent developments
    - 17.1.9.3.1 Deals
- 17.1.10 CELLECTIS S.A.
  - 17.1.10.1 Business overview
  - 17.1.10.2 Products/Services offered
  - 17.1.10.3 Recent developments
    - 17.1.10.3.1 Deals
- 17.1.11 REGENERON PHARMACEUTICALS, INC.
  - 17.1.11.1 Business overview
  - 17.1.11.2 Products/Services offered
  - 17.1.11.3 Recent developments
    - 17.1.11.3.1 Deals
- 17.1.12 AMSBIO
  - 17.1.12.1 Business overview
  - 17.1.12.2 Products/Services offered
- 17.1.13 CREATIVE BIOGENE
  - 17.1.13.1 Business overview
  - 17.1.13.2 Products/Services offered
- 17.1.14 SYNTHEGO
  - 17.1.14.1 Business overview
  - 17.1.14.2 Products/Services offered
  - 17.1.14.3 Recent developments
    - 17.1.14.3.1 Product/Service launches
    - 17.1.14.3.2 Deals
    - 17.1.14.3.3 Expansions
- 17.1.15 TAKARA BIO INC.
  - 17.1.15.1 Business overview
  - 17.1.15.2 Products/Services offered
  - 17.1.15.3 Recent developments
    - 17.1.15.3.1 Deals
    - 17.1.15.3.2 Expansions
- 17.1.16 BIO-TECHNE
  - 17.1.16.1 Business overview
  - 17.1.16.2 Products/Services offered
  - 17.1.16.3 Recent developments
    - 17.1.16.3.1 Deals
    - 17.1.16.3.2 Expansions
- 17.1.17 CARIBOU BIOSCIENCES, INC.
  - 17.1.17.1 Business overview
  - 17.1.17.2 Products/Services offered
  - 17.1.17.3 Recent developments
    - 17.1.17.3.1 Deals
- 17.1.18 BIONEER CORPORATION
  - 17.1.18.1 Business overview
  - 17.1.18.2 Products/Services offered
- 17.1.19 REPROCELL INC.
  - 17.1.19.1 Business overview
  - 17.1.19.2 Products/Services offered
17.2 OTHER PLAYERS
- 17.2.1 ALSTEM INC.
- 17.2.2 NEW ENGLAND BIOLABS
- 17.2.3 INSCRIPTA, INC.
- 17.2.4 BIOCAT GMBH.
- 17.2.5 INTEGRATED DNA TECHNOLOGIES, INC.
- 17.2.6 COBO TECHNOLOGIES APS
- 17.2.7 GENECOPOEIA, INC.
- 17.2.8 HERA BIOLABS
- 17.2.9 STEMCELL TECHNOLOGIES.
- 17.2.10 AXOL BIOSCIENCE LTD.
- 17.2.11 CELLECTA, INC.
- 17.2.12 APPLIED STEMCELL

18 APPENDIX

18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS

遺伝子編集の世界市場：製品別、サービス別、技法別、技術別、用途別 - 予測（～2029年）

Gene Editing Market by Product, Services, Technique, Technology, Application -Global Forecast to 2029

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場の概要

第6章 遺伝子編集市場：製品別

第7章 遺伝子編集製品市場：タイプ別

第8章 遺伝子編集試薬と消耗品市場：技法別

第9章 遺伝子編集製品市場：技術別

第10章 遺伝子編集製品市場：用途別

第11章 遺伝子編集製品市場：エンドユーザー別

第12章 遺伝子編集サービス市場：タイプ別

第13章 遺伝子編集サービス市場：用途別

第14章 遺伝子編集サービス市場：エンドユーザー別

第15章 遺伝子編集市場：地域別

第16章 競合情勢

第17章 企業プロファイル

第18章 付録